荟萃分析
医学
内科学
出版偏见
疾病
冠状动脉疾病
纳入和排除标准
心脏病学
病理
替代医学
作者
Feng Lu,Chengcheng Li,Yawei Li,Moning Guo
出处
期刊:PubMed
[National Institutes of Health]
日期:2019-11-06
卷期号:53 (11): 1152-1157
被引量:2
标识
DOI:10.3760/cma.j.issn.0253-9624.2019.11.015
摘要
Objective: Using Meta-analysis to evaluate the association between the short-term exposure to fine particular matter (PM(2.5)) and the morbidity of ischemic heart disease (IHD). Methods: In this paper, "particulate matter" , "PM2.5" , "ischemic heart disease" , "coronary heart disease" , "coronary artery disease" , "atherosclerotic heart disease" , and "atherosclerotic cardiovascular disease" were used to systematically search for the literature on the association between the short-term exposure to PM(2.5) and the ischemic heart disease through China Biology Medicine disc (CBMdisc), China National Knowledge Infrastructure (CNKI), Wanfang, Vip as well as Pubmed and Web of Science. The time was up to January 31(st) 2019. The quality of literature was evaluated by the Newcastle-Ottawa Scale. Meta-analysis method was performed by using R3.5.0 software and was used to perform heterogeneity test, calculate combined risk of IHD with short-term exposure to PM(2.5) and carry out publication bias test. Results: A total of 1 424 literatures were retrieved. Of the 23 literatures included studies (2 literatures in Chinese and 21 literatures in English) according to the inclusion and exclusion criteria, 14 used a time-series design and 9 used a case-crossover design. The heterogeneity existed across all identified studies (I(2)=81%, P<0.05). The Random effect model showed that a 10 μg/m(3) increase in PM(2.5) was associated with estimated relative risk of IHD morbidity at 1.007 (95%CI: 1.005-1.009); Publication bias was noted in the analysis (t=2.76, P<0.05), and the combined effect values of IHD morbidity was reduced to 1.005(95%CI: 1.004-1.007) after adjusting for asymmetry. Conclusion: Short-term exposure to PM(2.5) may lead to the increase of ischemic heart disease morbidity.
科研通智能强力驱动
Strongly Powered by AbleSci AI